Articles
Invion aims for Phase 3 smoking cessation trial
Invion claims that the results from its Phase 2 clinical trial of INV102 (nadolol) in patients trying to quit smoking warrant progression to a Phase 3 trial. [ + ]
Beauty is in the eye of the bee
What's the secret behind taking the winning image in a prestigious photomicrography competition? According to Queensland high school teacher Ralph Grimm, "It takes tons of patience, more than anything else." [ + ]
Lupus: in search of the wolf
A three-year-old patient, and a crucial discovery by Professor Carola Vinuesa's ANU research team, will transform diagnosis and treatment of lupus. [ + ]
Optics: small, light and fantastic
ANU biomedical engineer Dr Steve Lee has plans to turn your smartphone's camera into a portable, high-resolution, imaging microscope — and that's just one exciting application for his tiny, inexpensive polymer lenses.
[ + ]Blocking neuroblastoma
Scientists have identified a critical molecular 'feedback loop' that helps initiate and drive neuroblastoma — as well as a drug that has the potential to stop it. [ + ]
Accelerating the search for an HIV vaccine
The European AIDS Vaccine Initiative (EAVI2020) is a €23 million program to speed up the search for an effective HIV vaccine.
[ + ]Fusion drug achieves tumour reduction
Associate Professor Pilar Blancafort has conducted an expanded study to show that the biologics drug Omomyc, fused to a cell-penetrating Phylomer (1746), can be used to treat cancer. [ + ]
The importance of transparency
Studying experimental medicines in people is a vital part of the development process for all new medicines and vaccines. GSK Australia Medical Director Dr Andrew Weekes recognises the importance of publicly disclosing this research.
[ + ]Where sleeping malaria parasites lie
A study of malaria infection, illness and transmission rates among children in Papua New Guinea has yielded a therapeutic strategy that could quell or even eliminate infections by two of the most persistent malaria parasites: Plasmodium vivax and Plasmodium ovale. [ + ]
The nose knows best
Researchers have found that the colour of neuronal cells in the nose can be used to diagnose a rare genetic disorder called MELAS syndrome, which can result in stroke and dementia. [ + ]
The mystery of organic matter in lunar samples
Scientists have solved a mystery which has plagued NASA since the Apollo missions to the moon — the fact that samples of lunar soil brought back to Earth contained low levels of organic matter in the form of amino acids. [ + ]
Tennis elbow tendon treatment results
Orthocell has released positive follow-up data from a study of its tendon cell treatment for tennis elbow in workers compensation patients. [ + ]
The key to fighting sepsis
Australian and US researchers have identified a gene that triggers the inflammatory condition that can lead to the full-body infection sepsis. The gene's discovery could potentially lead to the development of new treatments for the deadly disease. [ + ]
The remarkable world of Raman imaging
At first glance, cement, cancer cells, interstellar dust, two-dimensional materials, billion-year-old microfossils, emulsions and the Kramers-Heisenberg-Dirac formula appear to have little if anything in common. [ + ]
Magnetic energy can change your brain — and your ideology
Researchers have used transcranial magnetic stimulation to temporarily shut down a region of the brain — specifically, the region that solves abstract problems addressed by ideology. [ + ]